Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project.
Almodovar R, Torre Alonso JC, Batlle E, Castillo C, Collantes-Estevez E, de Miguel E, González S, Gratacós J, Hernández A, Juanola X, Linares LF, Moreno MJ, Moreno M, Navarro-Compán V, Rodríguez Lozano C, Sanz J, Sellas A, Loza E, Zarco P; grupo de trabajo ONLY TOOLS. Almodovar R, et al. Among authors: torre alonso jc. Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):155-159. doi: 10.1016/j.reuma.2016.12.003. Epub 2017 Mar 9. Reumatol Clin (Engl Ed). 2018. PMID: 28284772 Free article. English, Spanish.
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.
Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Río J, Rodriguez Pérez A, Brautbar C, López-Larrea C. Gonzalez S, et al. Among authors: torre alonso jc. Arthritis Rheum. 1999 May;42(5):1010-6. doi: 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H. Arthritis Rheum. 1999. PMID: 10323458 Free article.
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study.
Collantes-Estevez E, Muñoz-Villanueva MC, Zarco P, Torre-Alonso JC, Gratacós J, González C, Sanmartí R, Cañete JD; Spanish Spondyloarthropathies Study Group. Collantes-Estevez E, et al. Among authors: torre alonso jc. Rheumatology (Oxford). 2005 Dec;44(12):1555-8. doi: 10.1093/rheumatology/kei085. Epub 2005 Aug 23. Rheumatology (Oxford). 2005. PMID: 16118228 Clinical Trial.
Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report.
Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL, Torre-Alonso JC, Gratacós J, González C, Batlle E, Fernández P, Linares LF, Brito E, Carmona L. Collantes E, et al. Among authors: torre alonso jc. Rheumatology (Oxford). 2007 Aug;46(8):1309-15. doi: 10.1093/rheumatology/kem084. Epub 2007 May 27. Rheumatology (Oxford). 2007. PMID: 17526930
High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study).
Navarro-Sarabia F, Fernández-Sueiro JL, Torre-Alonso JC, Gratacos J, Queiro R, Gonzalez C, Loza E, Linares L, Zarco P, Juanola X, Román-Ivorra J, Martín-Mola E, Sanmartí R, Mulero J, Diaz G, Armendáriz Y, Collantes E. Navarro-Sarabia F, et al. Among authors: torre alonso jc. Rheumatology (Oxford). 2011 Oct;50(10):1828-37. doi: 10.1093/rheumatology/ker083. Epub 2011 Jun 23. Rheumatology (Oxford). 2011. PMID: 21700683 Clinical Trial.
56 results